News
Ford Performance is developing another high-powered Mustang, reportedly equipped with the new "Legend" V8 engine ...
This phase II study demonstrated the efficacy of osimertinib 80 mg daily in patients with EGFR mutant NSCLC with leptomeningeal disease. The study designed included BICR using the RANO-LM assessment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results